Drug-induced hepatitis B virus reactivation: insights from FAERS database analysis
It was observed that some pharmaceuticals do not adequately address the risk of HBV-R in their drug documentation. These findings could assist healthcare providers in promptly recognizing drug-induced HBV-R.
Authors
- Genshan Zhang (ORCID: https://orcid.org/0009-0000-2545-0612)
- Lin Zhu (ORCID: https://orcid.org/0009-0007-0469-2250)
- Jie Fu (ORCID: https://orcid.org/0000-0001-5054-571X)
- Hao Yan (ORCID: https://orcid.org/0000-0002-5495-9001)
- Haokun Zhang
Institutions
- Gannan Medical University (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1080/14740338.2024.2438752
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39